I have specific biological experience and interest in inflammatory diseases.
My research experience originates from studies on polyunsaturated fatty acids (omega-3/6 PUFAs) metabolism, such as eicosanoids, and their role in multiple inflammatory diseases. My 19-year background in chromatography and mass spectrometry-based techniques together with more than a decade of working in pharmaceutical industry with drug development has lend me a broad scientific experience and an international network with a passion for joint collaborative team-work with clinicians, business developers and experimental scientists.
I use my bioanalytical experience to study inflammatory driving processes in asthma, (lipid mediators such as prostaglandin, leukotriene and related fatty acid), and key inflammatory plasma proteins in both asthma, rheumatoid arthritis and systemic sclerosis. I am excited about evaluating newly collected results from both in-vivo, ex-vivo and in vitro studies to progress new drug compounds, across the range from early drug discovery through-out clinical development.